Related Experiment Videos
Cardiomyopathy and encephalopathy in AIDS
A Antinori1, M L Giancola, L Alba
1National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy. antinori@inmi.it
Annals of the New York Academy of Sciences
|January 5, 2002
Summary
HIV-associated encephalopathy and cardiac dysfunction are common in AIDS patients. Mononuclear phagocytes drive neuroinflammation and cardiac issues, but antiretroviral therapy can mitigate these effects.
Area of Science:
- Neurology
- Cardiology
- Immunology
Background:
- HIV encephalopathy is a frequent neurological complication in AIDS patients.
- Subclinical cardiac abnormalities are prevalent in HIV-positive individuals, potentially linked to inflammatory mediators.
Purpose of the Study:
- To explore the relationship between neurological and cardiac manifestations in HIV infection.
- To investigate the role of mononuclear phagocytes in HIV-related CNS and cardiac damage.
Main Methods:
- Histological examination of brain tissue revealing astrocytosis, myelin pallor, and inflammatory cell infiltration.
- Analysis of inflammatory products and cytokines implicated in cardiac abnormalities.
Main Results:
- Mononuclear phagocytes are the primary targets for HIV-1 replication in the brain, releasing neurotoxic products.
- A common inflammatory pathway links neurological and cardiac dysfunction, suggesting cardiomyopathy may coexist with encephalopathy and impact survival.
Conclusions:
- HIV infection can lead to both neurological and cardiac complications, mediated by inflammatory processes.
- Antiretroviral therapy shows promise in reducing the impact of these abnormalities by suppressing viral load.